Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Heidi Kay
CEO and Founder

Message the company or request a 1:1 meeting here

Jericho Sciences is developing novel antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection.


Pitch Video

Tear Sheet

Executive Summary